Selective antagonism of EP2 receptor with AH6809 blocks increased expression of TGF-β1, collagen I and III in both cardiac myocytes and a chronic kidney disease-associated cardiac hypertrophy and fibrosis [20]. The gene discussed is TGFB1; the disease is chronic kidney disease.